COMP <GO>
FTLF vs ABBV // GROSS PROFIT MARGIN
FitLife Brands Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: FTLF 4
— ABBV 8
▲ GROSS PROFIT MARGIN LEADER: ABBV
LAST: $7.91 (-4.70%) • MKT CAP: $74.3M
gross-margins
43.10%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTLF VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FTLF | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 43.10% | 70.20% | -27.10 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.40% | 29.00% | -23.60 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.8x | 33.3x | -8.50 | FTLF | /valuation <GO> |
| Free Cash Flow Yield | 9.96% | 3.47% | +6.49 | FTLF | /fcf-yield <GO> |
| Operating Margin | 18.60% | 24.60% | -6.00 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 39.70% | 6.90% | +32.80 | FTLF | /net-margins <GO> |
| Revenue Growth (YoY) | — | 8.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.24 | 5.33 | -4.09 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.2 | 65.1 | -35.88 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.9x | 113.1x | -102.20 | FTLF | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $74.3M | $513.86B | -$513.79B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FTLF REV | ABBV REV | FTLF GROSS % | ABBV GROSS % | FTLF FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.9M | $61.16B | 43.1% | 70.2% | $7.4M | $17.82B |
| FY 2024 | $64.5M | $56.33B | 43.6% | 70.0% | $9.6M | $17.83B |
| FY 2023 | $0 | $54.32B | — | — | $4.2M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTLF // BETA —
ABBV // BETA 1.15